# OnCo record fes-pet (technology). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/technologies/fes-pet/>
  a schema:MedicalTherapy ;
  onco:kind "technology" ;
  schema:identifier "fes-pet" ;
  schema:name "FES PET (oestrogen receptor imaging)"@en ;
  schema:alternateName "18F-fluoroestradiol PET"@en, "Cerianna"@en, "oestrogen receptor PET"@en, "ER PET"@en ;
  schema:description "A PET scan using a radioactive form of oestrogen that lights up every tumour deposit still carrying the oestrogen receptor, so doctors can see whether metastases across the body will respond to hormone treatment without biopsying each one."@en ;
  schema:url <https://onco.cc/technologies/fes-pet/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://en.wikipedia.org/wiki/Fluoroestradiol_F-18> ;
  onco:status "approved" ;
  onco:cancers <https://onco.cc/cancers/breast-cancer/>, <https://onco.cc/cancers/breast-hr-positive/>, <https://onco.cc/cancers/metastatic-cancer/> ;
  onco:sections <https://onco.cc/fronts/imaging/> ;
  onco:technologies <https://onco.cc/technologies/pet/>, <https://onco.cc/technologies/pet-ct/>, <https://onco.cc/technologies/fdg-pet/>, <https://onco.cc/technologies/her2-pet/>, <https://onco.cc/technologies/psma-pet/>, <https://onco.cc/technologies/fapi-pet/>, <https://onco.cc/technologies/pet-tracer-manufacturing/>, <https://onco.cc/technologies/quantitative-imaging-biomarkers/> ;
  onco:targets <https://onco.cc/targets/estrogen-receptor/> ;
  onco:drugs <https://onco.cc/drugs/fulvestrant/>, <https://onco.cc/drugs/elacestrant/>, <https://onco.cc/drugs/tamoxifen/>, <https://onco.cc/drugs/letrozole/>, <https://onco.cc/drugs/trastuzumab-deruxtecan/> ;
  onco:companies <https://onco.cc/companies/ge-healthcare/> ;
  onco:terms <https://onco.cc/terms/esr1-mutation/> .